At a glance
ClinicalIndex Comparison RecordN/ACompleted· 465 enrolled
Drug / intervention
Virta Programother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake
In Brief
A clinical study evaluating Virta Program for Diabetes Mellitus, Type 2 and 2 related conditions. Completed, enrolled 465 participants across 1 site.
Detailed Summary
The primary purpose of this research is to demonstrate the therapeutic effects of implementing a well-formulated low carbohydrate lifestyle program over 2 years in patients with type 2 diabetes, pre-diabetes, and metabolic syndrome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Pre-diabetes, Metabolic Syndrome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartAug 2015
First PostedAug 2015
Primary CompletionApr 2018
Study CompletionApr 2021
TodayJul 2026
First PostedAug 10, 2015
Enrollment StartAug 1, 2015
Primary CompletionApr 1, 2018
Study CompletionApr 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 10.9 years ago
Interventions
Virta Programother